Transcriptomes of microglia in experimental cerebral malaria in mice in the presence and absence of Type i Interferon signaling

被引:6
|
作者
Talavera-López C. [1 ]
Capuccini B. [1 ,2 ]
Mitter R. [4 ]
Lin J.-W. [1 ,3 ]
Langhorne J. [1 ]
机构
[1] Malaria Immunology Laboratory, Francis Crick Institute, 1 Midland Road, London
[2] Polo di Genomica Genetica e Biologia, Via Fiorentina 1, Siena
[3] Division of Pediatric Infectious Diseases, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Collaboration Innovation Centre, Chengdu
[4] Bioinformatics and Biostatistics Team, Francis Crick Institute, 1 Midland Road, London
基金
英国医学研究理事会; 英国惠康基金;
关键词
Experimental cerebral malaria; Malaria; Microarray; Microglia; Plasmodium berghei; Type I Interferons;
D O I
10.1186/s13104-018-4020-3
中图分类号
学科分类号
摘要
Objectives: Plasmodium berghei ANKA infection in mice is a model for human cerebral malaria, the most severe complication of Plasmodium falciparum infection. Responses of brain microglia have been little investigated, and may contribute to the pathogenesis of cerebral malaria. We showed previously that microglia are activated in P. berghei infections, and that Type 1-Interferon signaling is important for activation. This dataset compares transcriptomic profiles of brain microglia of infected mice in the presence and absence of Type 1 interferon signaling, with the aim of identifying genes in microglia in this pathway during experimental cerebral malaria. Data description: We documented global gene expression from microglial RNA from uninfected and P berghei-infected wild-type C57BL/6 and IFNA Receptor Knock-out mice using Illumina Beadarrays. Principal component analysis showed 4 groups of samples corresponding to naïve wild-type, naïve IFNA Receptor knock-out, infected wild-type, and IFNA Receptor knock-out mice. Differentially-expressed genes of microglia from the two groups of infected mice are documented. Gene set enrichment analysis showing the top 500 genes assigned to Reactome pathways from infected IFNA Receptor knock-out versus naïve, and infected WT versus naïve has been generated. These data will be useful for those interested in microglia cells, and in experimental cerebral malaria. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [41] The type I interferon (IFN)-α mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor (IRF) 9
    Hofer, M. J.
    Li, W.
    Campbell, I. L.
    ACTA NEUROPATHOLOGICA, 2009, 118 (03) : 444 - 444
  • [42] The type I interferon (IFN)-α mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor (IRF) 9
    Hofer, Markus J.
    Li, Wen
    Campbell, Iain L.
    CYTOKINE, 2009, 48 (1-2) : 26 - 26
  • [43] Type I interferon-activated microglia are critical for neuromyelitis optica pathology
    Wlodarczyk, Agnieszka
    Khorooshi, Reza
    Marczynska, Joanna
    Holtman, Inge R.
    Burton, Mark
    Jensen, Kirstine Nolling
    Blaabjerg, Morten
    Meyer, Morten
    Thomassen, Mads
    Eggen, Bart J. L.
    Asgari, Nasrin
    Owens, Trevor
    GLIA, 2021, 69 (04) : 943 - 953
  • [44] Type-I-interferon-responsive microglia shape cortical development and behavior
    Escoubas, Caroline C.
    Dorman, Leah C.
    Nguyen, Phi T.
    Lagares-Linares, Christian
    Nakajo, Haruna
    Anderson, Sarah R.
    Barron, Jerika J.
    Wade, Sarah D.
    Cuevas, Beatriz
    Vainchtein, Ilia D.
    Silva, Nicholas J.
    Guajardo, Ricardo
    Xiao, Yinghong
    Lidsky, Peter V.
    Wang, Ellen Y.
    Rivera, Brianna M.
    Taloma, Sunrae E.
    Kim, Dong Kyu
    Kaminskaya, Elizaveta
    Nakao-Inoue, Hiromi
    Schwer, Bjoern
    Arnold, Thomas D.
    Molofsky, Ari B.
    Condello, Carlo
    Andino, Raul
    Nowakowski, Tomasz J.
    Molofsky, Anna V.
    CELL, 2024, 187 (08) : 1936 - 1954.e24
  • [45] Mice with type I interferon signaling deficiency are prone to epilepsy upon HSV-1 infection
    Yang, Wei
    Tang, Chong-Yang
    Fan, Dong-Ying
    Wang, Yi-Song
    Wang, Pei-Gang
    An, Jing
    Luan, Guo-Ming
    VIROLOGICA SINICA, 2024, 39 (02) : 251 - 263
  • [46] IL-17 promotes type I interferon signaling in autoimmune BXD2 mice
    Wang, John H.
    Chen, Jian
    Wu, Qi
    Yang, Ping-Ar
    Guentert, Tanja
    Hsu, Hui-Chen
    Mountz, John D.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S181 - S181
  • [47] Deficiency in Type I Interferon Signaling Prevents the Early Interferon-Induced Gene Signature in Pancreatic Islets but Not Type 1 Diabetes in NOD Mice
    Quah, Hong Sheng
    Miranda-Hernandez, Socorro
    Khoo, Aimee
    Harding, Ashley
    Fynch, Stacey
    Elkerbout, Lorraine
    Brodnicki, Thomas C.
    Baxter, Alan G.
    Kay, Thomas W. H.
    Thomas, Helen E.
    Graham, Kate L.
    DIABETES, 2014, 63 (03) : 1032 - 1040
  • [48] Role of Type I Interferon Signaling and Microglia in the Abnormal Long-term Potentiation and Object Place Recognition Deficits of Male Mice With a Mutation of the Tuberous Sclerosis 2 Gene
    Lopez-Aranda, Manuel F.
    Boxx, Gayle M.
    Phan, Miranda
    Bach, Karen
    Mandanas, Rochelle
    Herrera, Isaiah
    Taloma, Sunrae
    Thadani, Chirag
    Lu, Odilia
    Bui, Raymond
    Liu, Shuhan
    Li, Nan
    Zhou, Yu
    Cheng, Genhong
    Silva, Alcino J.
    BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2023, 3 (03): : 451 - 459
  • [49] Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models
    Blomberg, Evelina
    Silginer, Manuela
    Roth, Patrick
    Weller, Michael
    TRANSLATIONAL ONCOLOGY, 2023, 28
  • [50] Enrichment of type I interferon signaling in colonic group 2 innate lymphoid cells in experimental colitis
    Irie, Emi
    Ishihara, Rino
    Mizushima, Ichiro
    Hatai, Shunya
    Hagihara, Yuya
    Takada, Yoshiaki
    Tsunoda, Junya
    Iwata, Kentaro
    Matsubara, Yuta
    Yoshimatsu, Yusuke
    Kiyohara, Hiroki
    Taniki, Nobuhito
    Sujino, Tomohisa
    Takabayashi, Kaoru
    Hosoe, Naoki
    Ogata, Haruhiko
    Teratani, Toshiaki
    Nakamoto, Nobuhiro
    Mikami, Yohei
    Kanai, Takanori
    FRONTIERS IN IMMUNOLOGY, 2022, 13